Innovative Fingerprint Drug Screening Solution Showcased at the UK’s Premier Health and Safety Event
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical […]
Reliq Health Technologies, Inc. Announces Expansion of Contract with a Large US Healthcare Group to add over 30,000 New Patients to iUGO Care
HAMILTON, Ontario, May 17, 2024 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the […]
Bath & Body Works Declares Cash Dividend
COLUMBUS, Ohio, May 17, 2024 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today the declaration of […]
AMMO, Inc. Announces Preferred Stock Dividend
SCOTTSDALE, Ariz., May 17, 2024 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of […]
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical […]
Spectral AI Announces Purchases of Over 100,000 Shares by Insiders
DALLAS, May 17, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence […]
Gorilla Technology Releases Full Year Audited Financials for 2023
LONDON, May 17, 2024 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the “Company”), a global solution […]
REE Automotive to Report First Quarter 2024 Financial Results on May 30, 2024
TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive […]
American Rebel to Exhibit at the 153rd NRA Annual Meeting in Dallas, Texas
Nashville, TN, May 17, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a […]
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
BOSTON, May 17, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
